Treatment consent

Consent to Treatment & Medication

Important information about the medications SensibleDoc physicians may prescribe β€” including compounded medications β€” and the risks you should understand before starting treatment.

This document explains the treatments and medications that SensibleDoc physicians may prescribe and asks for your informed consent. It is in addition to the Telehealth Informed Consent. Please read it carefully and message your care team with any questions before you start treatment.

EMERGENCIES: If you experience a severe reaction (for example, difficulty breathing, swelling of the face or throat, severe abdominal pain, chest pain, or thoughts of harming yourself), stop the medication and call 911 or seek emergency care immediately.

1. Consent to treatment

You consent to evaluation and, if appropriate, treatment by a licensed physician at SensibleDoc. You understand the physician will rely on the information you provide, that no outcome is guaranteed, and that the physician may decline to prescribe, may prescribe an alternative, or may require additional information, labs, or an in-person visit.

2. Compounded medications β€” important disclosure

Some treatments offered through SensibleDoc are compounded medications prepared by state-licensed compounding pharmacies (503A pharmacies or 503B outsourcing facilities).

  • Compounded medications are NOT approved by the U.S. Food and Drug Administration (FDA). The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
  • Compounded medications are prepared for an individual patient based on a prescription and are not the same as FDA-approved brand-name or generic products.
  • The pharmacy is licensed and regulated by its state board of pharmacy and applicable federal law.
  • You consent to receive a compounded medication if your physician determines it is appropriate, and you understand the regulatory status described here.

3. Weight-loss therapy (GLP-1 / GIP) β€” risks to understand

If you are prescribed a GLP-1 / GIP medication (for example, compounded tirzepatide or semaglutide, often with B12), you should understand the following before starting:

  • Boxed warning: these medicines may cause thyroid C-cell tumors in animal studies. Do not use if you or a family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
  • Risk of pancreatitis (inflammation of the pancreas); stop and seek care for severe, persistent abdominal pain.
  • Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite; serious dehydration is possible.
  • Risk of gallbladder problems, low blood sugar (especially with other diabetes medicines), kidney problems from dehydration, and allergic reactions.
  • Not for use in pregnancy or while breastfeeding; tell your physician if you are or may become pregnant.

4. Sexual-health treatments β€” risks to understand

Erectile dysfunction (sildenafil, tadalafil)

  • Do NOT use these medications if you take nitrates or guanylate-cyclase stimulators (such as riociguat); the combination can cause a dangerous drop in blood pressure.
  • Seek emergency care for an erection lasting more than 4 hours (priapism) or sudden vision or hearing loss.
  • Tell your physician about heart conditions and all medications you take.

Premature ejaculation (sertraline, topical anesthetic)

  • Sertraline is an SSRI used off-label for premature ejaculation. It may cause nausea, drowsiness, reduced libido, or delayed ejaculation, and β€” uncommonly β€” new or worsening depression or thoughts of self-harm; seek care promptly for any such mood changes.
  • Do not combine sertraline with MAO inhibitors or other serotonergic medications without telling your physician (risk of serotonin syndrome).
  • A topical anesthetic may cause temporary numbness or skin irritation for you or your partner; use exactly as directed.

Low sexual desire in women (flibanserin, bremelanotide / PT-141)

  • Do NOT drink alcohol close to taking flibanserin (Addyi); the combination can cause severely low blood pressure and fainting. Avoid with certain medications (strong CYP3A4 inhibitors) and with liver problems; it may also cause dizziness, drowsiness, and nausea.
  • Bremelanotide (PT-141) may cause nausea, flushing, and headache, and a temporary rise in blood pressure; it is not for people with uncontrolled high blood pressure or known cardiovascular disease.
  • These treatments are intended for women; tell your physician if you are or may become pregnant.

5. Hair-restoration treatments β€” risks to understand

  • Finasteride is not for use by women who are or may become pregnant; it can cause birth defects and should not be handled by pregnant women when crushed or broken.
  • Possible sexual side effects (such as decreased libido or erectile changes), which may persist in some individuals.
  • Topical minoxidil/finasteride can cause scalp irritation; follow application instructions.

6. Your responsibilities

  • Take medications only as prescribed and do not share them.
  • Report side effects and any new medications, conditions, or pregnancy to your care team.
  • Complete any required labs and follow-ups.
  • Store and dispose of medications safely.

7. Shipping and dispensing

Medications are dispensed by a licensed pharmacy subject to the pharmacist's judgment and applicable law, and shipped to the address you provide. Keep your shipping address current. Risk of loss for shipping errors or delays is addressed in the Refund & Cancellation Policy.

8. Consent

By accepting this consent during intake, you acknowledge that you have read and understand the information above, including the compounded-medication disclosure and the program-specific risks relevant to your treatment, that you have had the opportunity to ask questions, and that you consent to treatment as your physician determines is appropriate.

The clinical risk disclosures in this document have been reviewed and approved by SensibleDoc’s medical director.